Clinical Trial: NAD Augmentation in Diabetes Kidney Disease
Study Status: Completed
Recruit Status: RECRUITING
Condition: Type2diabetes
Study Type: INTERVENTIONAL
Official Title: NAD Augmentation to Treat Diabetes Kidney Disease: A Randomized Controlled Trial
Brief Summary:
A phase 2a trial randomized, double-blind, placebo-controlled, parallel group trial to determine whether NMN administration improves DKD, as indicated by a significantly greater reduction in UACR compared with placebo administration.Eligible participants will be randomized to receive either 1000 mg NMN or placebo twice daily.
Read more